2026-00325Notice

FDA Embraces Bayesian Math to Fast-Track Drug Approvals

Published Date: 1/12/2026

Notice

Summary

The FDA just dropped a draft guide to help drug makers use Bayesian methods in clinical trials, making it easier to prove a drug’s safety and effectiveness. This affects companies testing new drugs and biologics, offering a fresh, smarter way to analyze trial results. Comments are open until March 13, 2026, so get your thoughts in early to shape the final rules—this could speed up approvals and save money down the road!

Analyzed Economic Effects

3 provisions identified: 3 benefits, 0 costs, 0 mixed.

Draft FDA guide allows Bayesian trials

If you are a sponsor or applicant (for INDs, NDAs, BLAs, or supplemental applications), the FDA published a draft guidance titled “Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products” that explains how to use Bayesian methods to support primary inference in pivotal clinical trials. The draft guidance is available for review and comment, and the FDA says it represents the Agency’s current thinking when finalized.

Informative priors and external data use

The draft guidance includes detailed considerations for using an informative prior to borrow external information in the primary analysis of a prospective trial. It also provides recommendations on choice of success criteria, evaluation of trial operating characteristics, and determination of the prior distribution.

Comment window and cost comments

FDA invites electronic or written comments on the draft guidance and asks that they be submitted by March 13, 2026 so the Agency can consider them before preparing a final version. FDA also states it will consider comments on costs or cost savings that the guidance may generate in its development of the final guidance.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
Comments Due
1/12/2026
3/13/2026

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML
Back to Federal Register

Take It Personal

Get Your Personalized Policy View

Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in